Translational Drug Development (TD2) is an oncology-focused Contract Research Organization (CRO) that supports improved and accelerated development of medicines for life-threatening diseases. We help companies move their drugs through the critical stages of preclinical, regulatory and clinical trial processes. Our scientific depth, proactive problem solving, and strategic direction and advice increase the likelihood of positive outcomes that bring hope and a better quality of life to cancer patients and their families.

TD2 was born from the Translational Genomics Research Institute (TGen) as a nonprofit in 2003. TGen’s deep scientific expertise and approach to interrogating the “omic” drivers of disease is at the heart of TD2’s heritage and has become the foundation upon which TD2 creates unique clinical strategies for its clients.

Clinical Trials

Life Sciences

Translational Drug Development (TD2)

Translational Drug Development (TD2)'s headquarters in Scottsdale, AZ, United States

Stephen Gately

Alan Miller M.D.

Susan Night

Marc Appelbaum

Shawnna Rustenbeck

The Clinical Data Management team at Translational Drug Development (TD2) is responsible for overseeing the collection, validation, and analysis of clinical trial data to ensure its accuracy and integrity. This team plays a critical role in managing data throughout the clinical trial process, facilitating timely decision-making, and supporting regulatory submissions. By employing stringent data management practices and collaborating closely with clinical teams, they aim to enhance the quality of data, ultimately contributing to the successful development of oncology therapies.

Clinical Data Management

The Data Management Team at Translational Drug Development (TD2) is responsible for the collection, organization, and analysis of clinical trial data to ensure accuracy and compliance with regulatory standards. This team collaborates closely with project managers and clinical staff to implement robust data management systems, streamline data workflows, and support data integrity throughout the drug development process, ultimately contributing to the successful advancement of oncology therapies.

Data Management Team

The Leadership Team at Translational Drug Development (TD2) guides the strategic direction and overall vision of the organization. Comprising key executives such as the CEO, Chief Medical Officer, and Vice Presidents of various operational sectors, this team is responsible for driving business growth, fostering innovation in oncology research, and ensuring the effective execution of clinical strategies. Through collaborative decision-making and leveraging industry expertise, they aim to enhance the drug development process, ultimately improving outcomes for cancer patients.

Leadership Team

The IT Team at Translational Drug Development (TD2) ensures the seamless operation and security of the technology infrastructure that supports the organization’s oncology research efforts. They manage IT systems, implement new technologies, and provide technical support to staff, enabling efficient data management and analysis throughout the drug development process. By leveraging innovative IT solutions, the team enhances collaboration and facilitates the timely and accurate delivery of critical research data.

Translational Drug Development (TD2)

Org chart

Teams

Clinical Data Management

Data Management Team

Leadership Team

IT Team

Offices

Translational Drug Development (TD2)

Org chart

Teams

Clinical Data Management

Data Management Team

Leadership Team

IT Team

Offices

Related companies